Welcome to our dedicated page for Tat Techn SEC filings (Ticker: TATT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TAT Technologies Ltd. filings document the company's foreign private issuer reporting, Form 6-K current reports and annual reporting framework under Form 20-F. Recent disclosures furnish press releases and investor presentations covering financial results, aerospace and defense service activities, MRO contract awards, OEM heat transfer solutions and aviation component work.
The filings also record governance matters, including shareholder meeting results and board changes, along with risk-factor references tied to annual reports. Contract-related reports describe MRO work for auxiliary power units and landing gear, while results filings disclose revenue, margins, operating income and other measures for the company's aerospace products and services business.
TAT Technologies Ltd. reported a board change. On November 14, 2025, Aviram Halevi concluded his term as a director after completing three years since his last appointment as an external director. The company expressed appreciation for his significant contribution and dedicated service during his tenure.
TAT Technologies Ltd. (Nasdaq: TATT) reported the results of its Annual and Special General Meeting of Shareholders. The company stated that all proposals presented in its proxy statement (furnished on September 29, 2025, with an amendment on October 20, 2025) were approved by the required majority in accordance with the Israeli Companies Law 5759-1999.
The meeting took place on November 4, 2025, at the offices of Naschitz, Brandes, Amir & Co. in Tel-Aviv, Israel. For specific proposal details, shareholders are directed to the company’s proxy statement.
TAT Technologies Ltd. furnished supplemental information for its Nov 4, 2025 Special General Meeting. The company withdrew a proposed change to its 2012 Incentive Plan and reinstated the clause that requires shareholder approval for Incentive Stock Option (ISO) grants within twelve months of the relevant Board resolution. If shareholder approval is not obtained in that period, options previously designated as ISOs will be treated as non‑qualified stock options (NQSO).
The company emphasizes that amendments to the Plan also require shareholder approval. All other proposed amendments to the 2012 Incentive Plan remain unchanged and will be presented under agenda item 6. The meeting date, location, and proxy materials are unchanged, and previously distributed proxy cards and ballots remain valid; shareholders who wish to revise their vote should follow the Proxy Statement’s “Voting and Proxies” instructions.
TAT Technologies Ltd. filed a Notice and Proxy Statement and a Form of Proxy Card for its Annual and Special Meeting scheduled for November 4, 2025. The excerpt confirms the proxy materials and the form of proxy will be used in connection with that meeting. The submission is signed by Ehud Ben‑Yair, Chief Financial Officer, with a signature date of September 29, 2025. The provided text does not include the meeting agenda, specific proposals, voting items, or any financial data.
TAT Technologies Ltd (TATT) filed a Form 144 notifying the proposed sale of 7,706 ordinary shares through Oppenheimer & Co. Inc., with an aggregate market value of $298,992.80. The shares represent approximately 0.07% of the 10,940,358 shares outstanding and are scheduled for sale on 09/17/2025 on NASDAQ. The filer acquired the securities on 03/06/2017 under an employee stock option plan and intends to pay cash upon exercise. The filing reports no sales by the same person in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
TAT Technologies Ltd (TATT) filed a Form 144 notifying the proposed sale of 7,706 ordinary shares through Oppenheimer & Co. Inc., with an aggregate market value of $298,992.80. The shares represent approximately 0.07% of the 10,940,358 shares outstanding and are scheduled for sale on 09/17/2025 on NASDAQ. The filer acquired the securities on 03/06/2017 under an employee stock option plan and intends to pay cash upon exercise. The filing reports no sales by the same person in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
TAT Technologies Ltd. filed a Form 144 notifying the proposed sale of 7,650 ordinary shares through Oppenheimer & Co. on 09/17/2025, with an aggregate market value of $296,820.00. The shares were acquired under an Employee Stock Option Plan on 05/13/2018 and will be paid in cash upon exercise. The filing lists 10,940,358 shares outstanding for the class, and discloses a prior sale by the same person of 7,311 shares on 08/14/2025 for $263,196.00. The filer certifies they are not aware of undisclosed material adverse information.
TAT Technologies Ltd. filed a Form 144 notifying the proposed sale of 7,650 ordinary shares through Oppenheimer & Co. on 09/17/2025, with an aggregate market value of $296,820.00. The shares were acquired under an Employee Stock Option Plan on 05/13/2018 and will be paid in cash upon exercise. The filing lists 10,940,358 shares outstanding for the class, and discloses a prior sale by the same person of 7,311 shares on 08/14/2025 for $263,196.00. The filer certifies they are not aware of undisclosed material adverse information.
TAT Technologies Ltd filings show that subsidiaries of Meitav Investment House Ltd reported beneficial holdings in the issuer's ordinary shares as of September 4, 2025. The filing discloses that Meitav Investment House Ltd (through its subsidiaries) beneficially owns 1,310,650 ordinary shares, representing 10.16% of the 12,898,582 shares outstanding reported on Bloomberg. Specifically, Meitav Provident Funds & Pension Ltd holds 1,002,049 shares (7.77%), Meitav Portfolio Management Ltd holds 218,384 shares (1.69%), and Meitav Tachlit Mutual Funds Ltd holds 90,217 shares (0.70%). The reporting persons state these subsidiaries manage funds and make independent voting and investment decisions and disclaim formation of a group or beneficial ownership beyond pecuniary interest.
TAT Technologies Ltd filings show that subsidiaries of Meitav Investment House Ltd reported beneficial holdings in the issuer's ordinary shares as of September 4, 2025. The filing discloses that Meitav Investment House Ltd (through its subsidiaries) beneficially owns 1,310,650 ordinary shares, representing 10.16% of the 12,898,582 shares outstanding reported on Bloomberg. Specifically, Meitav Provident Funds & Pension Ltd holds 1,002,049 shares (7.77%), Meitav Portfolio Management Ltd holds 218,384 shares (1.69%), and Meitav Tachlit Mutual Funds Ltd holds 90,217 shares (0.70%). The reporting persons state these subsidiaries manage funds and make independent voting and investment decisions and disclaim formation of a group or beneficial ownership beyond pecuniary interest.
TAT Technologies Ltd filings show that subsidiaries of Meitav Investment House Ltd reported beneficial holdings in the issuer's ordinary shares as of September 4, 2025. The filing discloses that Meitav Investment House Ltd (through its subsidiaries) beneficially owns 1,310,650 ordinary shares, representing 10.16% of the 12,898,582 shares outstanding reported on Bloomberg. Specifically, Meitav Provident Funds & Pension Ltd holds 1,002,049 shares (7.77%), Meitav Portfolio Management Ltd holds 218,384 shares (1.69%), and Meitav Tachlit Mutual Funds Ltd holds 90,217 shares (0.70%). The reporting persons state these subsidiaries manage funds and make independent voting and investment decisions and disclaim formation of a group or beneficial ownership beyond pecuniary interest.
TAT Technologies Ltd (TATT) filed a Form 144 reporting a proposed sale of 5,000 ordinary shares through Oppenheimer & Co. Inc. on 08/29/2025 with an aggregate market value of $188,650. The shares represent a portion of the company's reported 10,940,358 outstanding shares. The filer acquired the shares on 03/06/2024 under an Employee Stock Option Plan from the issuer and intends to pay cash upon exercise. The filing indicates no securities sold in the past three months for the account and includes the standard attestation that the seller is not aware of undisclosed material adverse information.